These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 24598682)
1. [Progress of study on circulating microRNAs in hematologic malignancies]. Qu Y; He HY; Hou J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):219-22. PubMed ID: 24598682 [TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890 [TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs: potential biomarkers for common malignancies. Khoury S; Tran N Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901 [TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Zen K; Zhang CY Med Res Rev; 2012 Mar; 32(2):326-48. PubMed ID: 22383180 [TBL] [Abstract][Full Text] [Related]
7. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. Cheng G Adv Drug Deliv Rev; 2015 Jan; 81():75-93. PubMed ID: 25220354 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in myeloid malignancies. Gordon JE; Wong JJ; Rasko JE Br J Haematol; 2013 Jul; 162(2):162-76. PubMed ID: 23679825 [TBL] [Abstract][Full Text] [Related]
9. Role of microRNAs in hematological malignancies. Fatica A; Bozzoni I Expert Rev Hematol; 2009 Aug; 2(4):415-23. PubMed ID: 21082946 [TBL] [Abstract][Full Text] [Related]
10. Targeting microRNA in hematologic malignancies. Han Z; Rosen ST; Querfeld C Curr Opin Oncol; 2020 Sep; 32(5):535-544. PubMed ID: 32657797 [TBL] [Abstract][Full Text] [Related]
11. The role of microRNAs in the pathogenesis and treatment of hematopoietic malignancies. Schmid CA; Craig VJ; Müller A; Flori M Curr Pharm Des; 2013; 19(7):1201-10. PubMed ID: 23092340 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression and function in cancer. Garzon R; Fabbri M; Cimmino A; Calin GA; Croce CM Trends Mol Med; 2006 Dec; 12(12):580-7. PubMed ID: 17071139 [TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Jin XF; Wu N; Wang L; Li J Cell Mol Neurobiol; 2013 Jul; 33(5):601-13. PubMed ID: 23633081 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in cancer: personalizing diagnosis and therapy. Nana-Sinkam SP; Fabbri M; Croce CM Ann N Y Acad Sci; 2010 Oct; 1210():25-33. PubMed ID: 20973796 [TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in hematological malignancies: a novel approach to targeted therapy. Joshi D; Gosh K; Vundinti BR Hematology; 2012 May; 17(3):170-5. PubMed ID: 22664117 [TBL] [Abstract][Full Text] [Related]
16. Hematological malignancies: role of miRNAs and their in silico aspects. Omer A; Yadav NK; Singh P; Singh RK Expert Rev Anticancer Ther; 2013 Sep; 13(9):1121-33. PubMed ID: 24053209 [TBL] [Abstract][Full Text] [Related]
17. Circulating miRNAs as biomarkers for early diagnosis of coronary artery disease. Zhang L; Zhang Y; Zhao Y; Wang Y; Ding H; Xue S; Li P Expert Opin Ther Pat; 2018 Aug; 28(8):591-601. PubMed ID: 30064285 [TBL] [Abstract][Full Text] [Related]
18. [Relationship between microRNA-155 and hematological malignancies]. Xue H; Hua LM; Luo JM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):810-4. PubMed ID: 23815946 [TBL] [Abstract][Full Text] [Related]
19. Distribution of microRNA biomarker candidates in solid tissues and body fluids. Fehlmann T; Ludwig N; Backes C; Meese E; Keller A RNA Biol; 2016 Nov; 13(11):1084-1088. PubMed ID: 27687236 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-binding site polymorphisms in hematological malignancies. Dzikiewicz-Krawczyk A J Hematol Oncol; 2014 Nov; 7():83. PubMed ID: 25421940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]